Verve Therapeutics Stock Price History

VERV Stock  USD 3.18  0.23  6.74%   
If you're considering investing in Verve Stock, it is important to understand the factors that can impact its price. As of today, the current price of Verve Therapeutics stands at 3.18, as last reported on the 11th of April 2025, with the highest price reaching 3.53 and the lowest price hitting 2.86 during the day. Verve Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0952, which indicates the firm had a -0.0952 % return per unit of risk over the last 3 months. Verve Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verve Therapeutics' Coefficient Of Variation of (830.38), variance of 36.95, and Risk Adjusted Performance of (0.18) to confirm the risk estimate we provide.
  
At this time, Verve Therapeutics' Common Stock Total Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 45.4 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 351.6 M in 2025. . At this time, Verve Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 0.10 in 2025, whereas Price Earnings Ratio is likely to drop (2.51) in 2025. Verve Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0952

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVERV

Estimated Market Risk

 6.15
  actual daily
54
54% of assets are less volatile

Expected Return

 -0.59
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Verve Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verve Therapeutics by adding Verve Therapeutics to a well-diversified portfolio.
Price Book
0.6137
Enterprise Value Ebitda
(0.40)
Price Sales
8.3764
Shares Float
65 M
Wall Street Target Price
23.3178

Verve Therapeutics Stock Price History Chart

There are several ways to analyze Verve Stock price data. The simplest method is using a basic Verve candlestick price chart, which shows Verve Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 5, 20258.63
Lowest PriceApril 8, 20252.97

Verve Therapeutics April 11, 2025 Stock Price Synopsis

Various analyses of Verve Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Verve Stock. It can be used to describe the percentage change in the price of Verve Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Verve Stock.
Verve Therapeutics Price Rate Of Daily Change 0.93 
Verve Therapeutics Price Daily Balance Of Power(0.34)
Verve Therapeutics Price Action Indicator(0.13)

Verve Therapeutics April 11, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Verve Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Verve Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Verve Stock and then apply it to test your longer-term investment strategies against Verve.

Verve Stock Price History Data

The price series of Verve Therapeutics for the period between Sat, Jan 11, 2025 and Fri, Apr 11, 2025 has a statistical range of 5.66 with a coefficient of variation of 21.63. The daily prices for the period are distributed with arithmetic mean of 6.38. The median price for the last 90 days is 6.32.
OpenHighLowCloseVolume
04/11/2025
 3.41  3.53  2.86  3.18 
04/11/2025
 3.41  3.53  2.86  3.18 
04/09/2025 2.89  3.53  2.86  3.41  4,095,275 
04/08/2025 3.53  3.61  2.91  2.97  2,354,452 
04/07/2025 3.42  3.63  3.10  3.34  3,281,717 
04/04/2025 3.70  3.74  3.46  3.62  2,165,768 
04/03/2025 3.79  3.96  3.68  3.85  2,477,305 
04/02/2025 4.10  4.42  3.77  3.91  2,585,902 
04/01/2025 4.56  4.56  4.10  4.14  1,989,228 
03/31/2025 5.02  5.02  4.54  4.57  1,900,157 
03/28/2025 5.23  5.40  5.15  5.22  585,375 
03/27/2025 5.47  5.47  5.19  5.28  853,586 
03/26/2025 5.84  5.88  5.31  5.40  1,370,036 
03/25/2025 5.80  5.92  5.46  5.84  923,020 
03/24/2025 5.64  5.99  5.60  5.78  978,627 
03/21/2025 5.35  5.62  5.26  5.55  1,163,491 
03/20/2025 5.82  5.92  5.40  5.54  943,014 
03/19/2025 5.77  5.91  5.63  5.89  698,647 
03/18/2025 6.21  6.21  5.77  5.77  1,016,569 
03/17/2025 5.98  6.42  5.79  6.32  1,320,909 
03/14/2025 6.25  6.35  5.90  5.97  676,140 
03/13/2025 6.40  6.59  5.99  6.15  1,094,965 
03/12/2025 6.27  6.61  6.24  6.42  1,363,540 
03/11/2025 5.89  6.22  5.57  6.16  1,423,764 
03/10/2025 6.60  6.73  5.64  5.95  1,868,435 
03/07/2025 6.59  6.81  6.27  6.71  1,548,647 
03/06/2025 6.36  6.66  6.00  6.61  1,545,942 
03/05/2025 6.18  6.58  5.91  6.55  1,608,822 
03/04/2025 5.86  6.17  5.68  6.12  1,498,464 
03/03/2025 6.35  6.43  6.04  6.17  1,902,481 
02/28/2025 6.27  6.33  5.99  6.33  1,629,946 
02/27/2025 6.28  6.56  6.06  6.20  1,511,220 
02/26/2025 6.56  6.63  6.22  6.31  1,318,929 
02/25/2025 7.04  7.09  6.38  6.45  1,763,419 
02/24/2025 7.36  7.36  6.79  7.03  1,109,624 
02/21/2025 8.00  8.03  7.02  7.28  1,176,559 
02/20/2025 8.06  8.06  7.65  7.83  1,056,473 
02/19/2025 8.41  8.52  7.86  8.07  1,107,827 
02/18/2025 8.64  9.31  8.32  8.49  1,583,693 
02/14/2025 7.82  8.87  7.82  8.58  1,406,075 
02/13/2025 8.20  8.22  7.54  7.71  1,077,043 
02/12/2025 7.63  8.05  7.44  8.04  777,947 
02/11/2025 7.90  8.00  7.62  7.81  831,803 
02/10/2025 8.19  8.26  7.65  7.98  1,633,442 
02/07/2025 8.32  8.52  8.06  8.16  1,073,919 
02/06/2025 8.75  8.77  8.18  8.36  1,380,211 
02/05/2025 8.21  8.77  8.15  8.63  1,931,860 
02/04/2025 7.90  8.22  7.57  8.06  2,199,486 
02/03/2025 7.30  7.57  6.95  7.52  1,316,845 
01/31/2025 7.44  7.90  7.38  7.61  1,290,735 
01/30/2025 7.84  7.96  7.39  7.41  1,140,636 
01/29/2025 7.25  7.98  7.25  7.70  1,038,704 
01/28/2025 7.63  7.65  7.00  7.25  1,378,415 
01/27/2025 7.86  8.05  7.61  7.76  1,267,180 
01/24/2025 7.99  8.54  7.81  7.91  2,271,681 
01/23/2025 7.73  8.70  7.71  7.99  3,876,102 
01/22/2025 6.62  8.00  6.62  7.80  4,666,230 
01/21/2025 6.25  6.90  6.15  6.57  2,125,323 
01/17/2025 6.11  6.58  6.10  6.14  1,645,781 
01/16/2025 5.52  6.14  5.32  6.10  1,735,387 
01/15/2025 5.50  5.80  5.33  5.49  1,249,116 

About Verve Therapeutics Stock history

Verve Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verve is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verve Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verve Therapeutics stock prices may prove useful in developing a viable investing in Verve Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding84.6 M63.8 M
Net Loss-141.6 M-134.6 M

Verve Therapeutics Quarterly Net Working Capital

499.84 Million

Verve Therapeutics Stock Technical Analysis

Verve Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Verve Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Verve Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Verve Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Verve Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Verve Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verve to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Verve Stock Analysis

When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.